# Association between GLP-1 receptor agonist use and risk of repeat colonoscopy: a real-world cohort study with exploratory discontinuation analyses

Source: [Medical research : nature.com subject feeds](https://www.nature.com/articles/s41598-026-79042-8) · 2026-11-11 · Medicine
Page: https://themorning.science/story/association-between-glp-1-receptor-agonist-use-and-risk-of-repeat-colonoscopy-a-8547269a907eb2f8
Kind: research · Impact: low

## In brief

- A real-world cohort study examined whether GLP-1 receptor agonist use is associated with risk of repeat colonoscopy.
- The paper also includes exploratory analyses of discontinuation of GLP-1 receptor agonists.
- The source feed provided only the title and link, with no summary available.

## Why it matters

Repeat colonoscopy is a common, costly part of colorectal screening and surveillance, so findings on whether GLP-1 receptor agonist use is linked to it may matter for clinicians and patients using these drugs.

## Timeline

- 2026-11-11: Article listed in nature.com subject feed

## Coverage

- [Association between GLP-1 receptor agonist use and risk of repeat colonoscopy: a real-world cohort study with exploratory discontinuation analyses](https://www.nature.com/articles/s41598-026-79042-8) — Medical research : nature.com subject feeds, 2026-11-11

Tags: glp-1, colonoscopy, colorectal screening, real-world evidence, cohort study

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science